Cas 1030626-29-9,4-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]-benzamide

1030626-29-9

Post Buying Request

Basic information

Product Name: 4-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]-benzamide
Synonyms: 4-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]-benzamide
CAS NO:1030626-29-9
Molecular Formula:
Molecular Weight: 414.467
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]-benzamide(CAS DataBase Reference)
NIST Chemistry Reference: 4-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]-benzamide(1030626-29-9)
EPA Substance Registry System: 4-[8-(4-morpholin-4-yl-phenylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]-benzamide(1030626-29-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1030626-29-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1030626-29-9 Suppliers

Recommended suppliers

1030626-29-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1030626-29-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,0,6,2 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1030626-29:
(9*1)+(8*0)+(7*3)+(6*0)+(5*6)+(4*2)+(3*6)+(2*2)+(1*9)=99
99 % 10 = 9
So 1030626-29-9 is a valid CAS Registry Number.

1030626-29-9Upstream product

1030626-29-9Downstream Products

1030626-29-9Relevant academic research and scientific papers

TRIAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE and INFLAMMATORY DISEASES

-

Page/Page column 100, (2008/12/06)

Novel triazolopyridine compounds are disclosed that have a formula represented by Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non- limiting example, ECM degradation, joint degradation and/or inflammation, and others.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1030626-29-9